26 related articles for article (PubMed ID: 38703896)
1. Impact of polypharmacy on 3-year mortality in patients with heart failure: a retrospective study.
Hayashi D; Kubota Y; Nishino T; Watanabe Y; Iwade Y; Matsuda J; Kato K; Tara S; Ise Y; Iwasaki YK; Asai K
J Pharm Health Care Sci; 2024 Jul; 10(1):34. PubMed ID: 38956739
[TBL] [Abstract][Full Text] [Related]
2. Clinical Decision Support Tools for Optimizing Guideline-Directed Medical Therapy for Heart Failure: Computing the Possibilities.
Ng TMH
JACC Adv; 2023 May; 2(3):100354. PubMed ID: 38939604
[TBL] [Abstract][Full Text] [Related]
3. Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study.
Chen TH; Li YR; Chen SW; Lin YS; Sun CC; Chen DY; Mao CT; Wu M; Chang CH; Chu PH; Wu VC
Cardiovasc Diabetol; 2020 Nov; 19(1):189. PubMed ID: 33167990
[TBL] [Abstract][Full Text] [Related]
4. Navigating Heart Failure: Unveiling Sex Disparities in Guideline-Directed Medical Therapy Combinations.
Celik A; Sahin A; Ata N; Colluoglu IT; Ural D; Kanik EA; Ayvali MO; Ulgu MM; Birinci S; Yilmaz MB
Am J Cardiol; 2024 Apr; 216():27-34. PubMed ID: 38266795
[TBL] [Abstract][Full Text] [Related]
5. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
Hippisley-Cox J; Coupland C
BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
[TBL] [Abstract][Full Text] [Related]
6. Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus.
Evans JM; Doney AS; AlZadjali MA; Ogston SA; Petrie JR; Morris AD; Struthers AD; Wong AK; Lang CC
Am J Cardiol; 2010 Oct; 106(7):1006-10. PubMed ID: 20854965
[TBL] [Abstract][Full Text] [Related]
7. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.
Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
Diabetes Care; 2005 Oct; 28(10):2345-51. PubMed ID: 16186261
[TBL] [Abstract][Full Text] [Related]
8. Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy.
Çöllüoğlu İT; Çelik A; Ata N; Ural D; Şahin A; Ulgu MM; Kanık EA; Birinci Ş; Yılmaz MB
Int J Cardiol; 2024 Jul; 407():132109. PubMed ID: 38703896
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis.
Maruthur NM; Tseng E; Hutfless S; Wilson LM; Suarez-Cuervo C; Berger Z; Chu Y; Iyoha E; Segal JB; Bolen S
Ann Intern Med; 2016 Jun; 164(11):740-51. PubMed ID: 27088241
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.
Bennett WL; Maruthur NM; Singh S; Segal JB; Wilson LM; Chatterjee R; Marinopoulos SS; Puhan MA; Ranasinghe P; Block L; Nicholson WK; Hutfless S; Bass EB; Bolen S
Ann Intern Med; 2011 May; 154(9):602-13. PubMed ID: 21403054
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.
Fonarow GC
Am Heart J; 2004 Oct; 148(4):551-8. PubMed ID: 15459582
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
